Mostrar el registro sencillo del ítem

dc.contributor.authorSi, Shuqing
dc.contributor.authorBi, Anbreen
dc.contributor.authorYu, Zhaoying
dc.contributor.authorSee, Cheryl
dc.contributor.authorKelly, Sinead
dc.contributor.authorAmbrogi, Sonia
dc.contributor.authorArango, Celso
dc.contributor.authorBaeza, Inmaculada
dc.contributor.authorBanaj, Nerisa
dc.contributor.authorBerk, Michael
dc.contributor.authorCastro-Fornieles, Josefina
dc.contributor.authorCrespo-Facorro, Benedicto
dc.contributor.authorCrouse, Jacob
dc.contributor.authorMartínez Díaz-Caneja, Covadonga
dc.contributor.authorFett, Anne-Kathrin
dc.contributor.authorFortea, Adriana
dc.contributor.authorFrangou, Sophia
dc.contributor.authorGoldstein, Benjamin I.
dc.contributor.authorHickie, Ian
dc.contributor.authorJanssen, Joost
dc.contributor.authorKennedy, Kody
dc.contributor.authorKrabbendam, Lydia
dc.contributor.authorKyriakopoulos, Marinos
dc.contributor.authorMacIntosh, Bradley
dc.contributor.authorMorgado, Pedro
dc.contributor.authorNerland, Stener
dc.contributor.authorPascual-Diaz, Saül
dc.contributor.authorPicó-Pérez, Maria
dc.date.accessioned2024-03-01T12:22:42Z
dc.date.available2024-03-01T12:22:42Z
dc.date.issued2024
dc.identifier.citationSi, S., Bi, A., Yu, Z. et al. Mapping gray and white matter volume abnormalities in early-onset psychosis: an ENIGMA multicenter voxel-based morphometry study. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-023-02343-1ca_CA
dc.identifier.urihttp://hdl.handle.net/10234/206112
dc.description.abstractINTRODUCTION: Regional gray matter (GM) alterations have been reported in early-onset psychosis (EOP, onset before age 18), but previous studies have yielded conflicting results, likely due to small sample sizes and the different brain regions examined. In this study, we conducted a whole brain voxel-based morphometry (VBM) analysis in a large sample of individuals with EOP, using the newly developed ENIGMA-VBM tool. METHODS: 15 independent cohorts from the ENIGMA-EOP working group participated in the study. The overall sample comprised T1-weighted MRI data from 482 individuals with EOP and 469 healthy controls. Each site performed the VBM analysis locally using the standardized ENIGMA-VBM tool. Statistical parametric T-maps were generated from each cohort and meta-analyzed to reveal voxel-wise differences between EOP and healthy controls as well as the individual-based association between GM volume and age of onset, chlorpromazine (CPZ) equivalent dose, and other clinical variables. RESULTS: Compared with healthy controls, individuals with EOP showed widespread lower GM volume encompassing most of the cortex, with the most marked effect in the left median cingulate (Hedges’ g = 0.55, p = 0.001 corrected), as well as small clusters of lower white matter (WM), whereas no regional GM or WM volumes were higher in EOP. Lower GM volume in the cerebellum, thalamus and left inferior parietal gyrus was associated with older age of onset. Deficits in GM in the left inferior frontal gyrus, right insula, right precentral gyrus and right superior frontal gyrus were also associated with higher CPZ equivalent doses. CONCLUSION: EOP is associated with widespread reductions in cortical GM volume, while WM is affected to a smaller extent. GM volume alterations are associated with age of onset and CPZ equivalent dose but these effects are small compared to case-control differences. Mapping anatomical abnormalities in EOP may lead to a better understanding of the role of psychosis in brain development during childhood and adolescence.ca_CA
dc.format.extent9 p.ca_CA
dc.format.mimetypeapplication/pdfca_CA
dc.language.isoengca_CA
dc.publisherSpringer Natureca_CA
dc.relation.isPartOfMolecular Psychiatry (2024)ca_CA
dc.rights© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.ca_CA
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/ca_CA
dc.titleMapping gray and white matter volume abnormalities in earlyonset psychosis: an ENIGMA multicenter voxel-based morphometry studyca_CA
dc.typeinfo:eu-repo/semantics/articleca_CA
dc.identifier.doihttps://doi.org/10.1038/s41380-023-02343-1
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/101034377
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/777394
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_CA
dc.relation.publisherVersionhttps://www.nature.com/articles/s41380-023-02343-1ca_CA
dc.type.versioninfo:eu-repo/semantics/publishedVersionca_CA
project.funder.nameGobierno de la Comunidad de Madridca_CA
project.funder.nameEuropean Union (EU)ca_CA
project.funder.nameEuropean Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertakingca_CA
project.funder.nameNextGenerationEU/PRTRca_CA
project.funder.nameAgencia Estatal de Investigaciónca_CA
project.funder.nameEuropean Commissionca_CA
oaire.awardNumberS2022/BMD-7216ca_CA
oaire.awardNumber1978-1998ca_CA
oaire.awardNumberS2022/BMD-7216 (AGES 3-CM)ca_CA
oaire.awardNumber2004-259ca_CA
oaire.awardNumber2006-186ca_CA
oaire.awardNumberRYC2021-031228-Ica_CA
oaire.awardNumberMCIN/AEI/10.13039/50110 0011033ca_CA
oaire.awardNumberJR19/00024ca_CA
oaire.awardNumberPI02100330ca_CA
oaire.awardNumberPI18/00976ca_CA
oaire.awardNumberPI19/01024ca_CA
oaire.awardNumberPI20/00654ca_CA
oaire.awardNumberPI20/00721ca_CA
oaire.awardNumberPMP21/00051ca_CA


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.
Excepto si se señala otra cosa, la licencia del ítem se describe como: © The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.